Cargando…
Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer's disease patients: A comparison between visual and quantitative assessment
NIA-AA diagnostic criteria include volumetric or visual rating measures of hippocampal atrophy (HA) as a diagnostic biomarker of Alzheimer's disease (AD). We aimed to determine its utility as a diagnostic biomarker for early onset Alzheimer's disease (EOAD) by assessing Medial Temporal Atr...
Autores principales: | Falgàs, Neus, Sánchez-Valle, Raquel, Bargalló, Núria, Balasa, Mircea, Fernández-Villullas, Guadalupe, Bosch, Beatriz, Olives, Jaume, Tort-Merino, Adrià, Antonell, Anna, Muñoz-García, Cristina, León, María, Grau, Oriol, Castellví, Magdalena, Coll-Padrós, Nina, Rami, Lorena, Redolfi, Alberto, Lladó, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627030/ https://www.ncbi.nlm.nih.gov/pubmed/31491836 http://dx.doi.org/10.1016/j.nicl.2019.101927 |
Ejemplares similares
-
Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
por: Contador, José, et al.
Publicado: (2021) -
Early‐onset Alzheimer's disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late‐onset
por: Tort‐Merino, Adrià, et al.
Publicado: (2022) -
Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
por: Falgàs, Neus, et al.
Publicado: (2020) -
The
APOE4
effect: structural brain differences in Alzheimer's disease according to the age at symptom onset
por: Forno, Gonzalo, et al.
Publicado: (2022) -
Classifying Alzheimer's disease and frontotemporal dementia using machine learning with cross‐sectional and longitudinal magnetic resonance imaging data
por: Pérez‐Millan, Agnès, et al.
Publicado: (2023)